FDA Inspection 1163257 — BioLife Plasma Services
The FDA completed an inspection of BioLife Plasma Services on Feb 9, 2022 in Madison, WI. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 9, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Madison, WI (United States)